Mobile App-assisted Behavioral Treatment in Children and Adolescents With Tics
Mobile App-assisted Behavioral Treatment (MA-BT) in Children and Adolescents With a Chronic Tic Disorder. Randomized Clinical Trial Evaluating Treatment Response and Satisfaction
Chronic tic disorders are neurodevelopmental disorders affecting 0.5-1% of children and adolescents. Tics present as sudden, rapid, repetitive non-rhythmic movements or vocalizations or a combination. Tics may be extremely distressing in a child's life, but the severity of tics is often variable. The group of children/ adolescents with tic disorders are heterogenous when it comes to symptom presentation, comorbid conditions and social status. This places great demands on professionals to offer the right treatment at the right time. The aim of the current project is to make optimal tics training more accessible, including for patients managed in primary care, to make optimal treatment available in the immediate environment, and to ensure increased adherence to treatment.
As part of this project, an app has been developed and the study aims to evaluate mobile app-assisted behavioral treatment as an efficient and feasible approach that may be a valuable tool together with other treatment approaches. The mobile app-assisted training is based on the manual "Niks til Tics", which describes training with a combination of Habit Reversal Training (HRT) and Exposure Response Prevention (ERP) over eight sessions, and a booster session. Both HRT and ERP are known to be effective treatments of tics.
In this project a randomized controlled superiority trial evaluates the effect of app-assisted training versus an educational approach. Participants are randomized to manualised treatment combining HRT and ERP as app-assisted training, or to psychoeducation. The participants are included according to the same criteria as in a pilot trial, and primary outcome measure is YGTSS at session 8. Furthermore, the change in tics intensity from the first contact to baseline will be included as to evaluate the effect of being admitted and examined at the hospital.
This project contributes to increased knowledge about tics and tic treatment especially treatment using digital based interventions. An app has been developed for this project and the hypothesis is that a mobile app-assisted tic training program requiring minimal hospital contacts is superior to app-based psychoeducation alone, which is the most likely intervention that these patients will be offered.
This registration encompasses a project that collects information/data for multiple publications. As such, a number of publications are planned including a description of acute outcome, potential predictors, and longterm treatment effect
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: judith nissen, phd
- Phone Number: +4529931523
- Email: judiniss@rm.dk
Study Locations
-
-
Risskov
-
Aarhus N, Risskov, Denmark, 8240
- Recruiting
- AarhusUH
-
Contact:
- judith nissen, phd
- Phone Number: 29931523
- Email: judiniss@rm.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- a primary diagnosis of a chronic motor/vocal tics disorder including Tourette syndrome according to the WHO ICD-10 diagnostic criteria and Statistical Manual of Mental Disorders
- a total tic score higher than 13 on the Yale Global Tic Severity Scale (YGTSS), or above a tic score of 9, if only motor or vocal tics are present
Exclusion Criteria:
- psychotic disorder
- primary severe depression
- suicidal ideation or attempts
- primary severe eating disorder
- IQ below 70 (mental retardation)
- participation in tic training based on HRT/ERP treatment within 6 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: digital tic training
The active treatment including apps released for every session
|
The app-assisted training group has access to a newly developed app in which they are taught how to handle tics.
A new app session is released at each new treatment session and the content of the app videos is comparable to the information and training at face-to-face individual treatment, as defined by the manual "Niks to Tics"[
|
|
Active Comparator: digital tic learner
The control arm including apps released in the first session
|
The app-assisted educational group has access to a newly developed app in which they receive psychoeducation on tics.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of baseline Yale Global Tic Severity Scale (YGTSS) at 5 weeks, 15 weeks, 23 weeks, 75-96 weeks
Time Frame: Baseline, 5 weeks, 15 weeks, 23 weeks, 75-96 weeks
|
YGTSS - a clinician-administered semi-structured interview including a checklist of all tic symptoms
|
Baseline, 5 weeks, 15 weeks, 23 weeks, 75-96 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of baseline premonitory urge scale (PUTS)
Time Frame: Baseline, 5 weeks, 15 weeks, 23 weeks, 75-96 weeks
|
PUTS is a short self-reporting scale with nine items
|
Baseline, 5 weeks, 15 weeks, 23 weeks, 75-96 weeks
|
|
Change of baseline beliefs about tics scale (BATS)
Time Frame: Baseline, 5 weeks, 15 weeks, 23 weeks, 75-96 weeks
|
BATS is a self-reporting scale with 20 items
|
Baseline, 5 weeks, 15 weeks, 23 weeks, 75-96 weeks
|
|
Change of baseline parent and child self-evaluating questionnaire
Time Frame: Baseline, 5 weeks, 15 weeks, 23 weeks, 75-96 weeks
|
Based on PTQ - a parent evaluating questionnaire
|
Baseline, 5 weeks, 15 weeks, 23 weeks, 75-96 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Per Thomsen, Phd, Department of Child and Adolescent Psychiatry, Aarhus University Hospital, Psychiatry, Aarhus, Denmark
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1-16-02-355-21
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.